Health Condition 1: L700- Acne vulgaris
Conditions
Interventions
Intervention1: Topical combination of 1% clindamycin gel and 2.5% benzoyl peroxide gel: once daily at night
Control Intervention1: Topical 1% clindamycin gel: once daily at night
Sponsors
dr simran thory
Eligibility
Inclusion criteria
Inclusion criteria: Individuals of either gender aged 14 to 40 years. Clinically diagnosed with mild to moderate acne vulgaris. Investigator Global Assessment score of 2 or 3. Willing to provide written informed consent and adhere to study protocol and follow up visits.
Exclusion criteria
Exclusion criteria: Use of any topical or systemic medication for the treatment of acne vulgaris within the preceding one month. Presence of severe inflammatory acne such as nodulocystic acne. Known hypersensitivity to any of the study medications including benzoyl peroxide or clindamycin. Pregnant or lactating women. History of use of corticosteroids, anti tubercular therapy or anti epileptic drugs. Underlying medical conditions including polycystic ovarian disease or hepatic impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Investigator Global Assessment score from baseline to Week 12.Timepoint: Change in Investigator Global Assessment score from baseline, 4th week ,8th week and Week 12. | — |
Secondary
| Measure | Time frame |
|---|---|
| incidence and severity of adverse effect during the study periodTimepoint: throughout study period | — |
Countries
India
Contacts
Public ContactDr K Girish
kempegowda institute of medical sciences
Outcome results
None listed